CSI Market
Sign In | Register

Abbvie Inc (ABBV) Annual Income Statement

Annual · GAAP · USD millions
Access ABBV quarterly income statements →
By examining income statement figures across successive periods, users can identify shifts in Abbvie Inc's profitability and expense structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
2025 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Total Revenue61,160.00
Costs & Expenses
Cost of Goods and Services Sold18,204.00
Gross Profit42,956.00
Selling, Administration, Marketing14,010.00
Research & Development9,096.00
Other exp. /-income4,775.00
Total operating costs including COS46,085.00
Operating income / -loss15,075.00
Interest Expense2,627.00
Net Interest (-)Expense / Income-2,627.00
Foreign Currency Transaction Gain (Loss), before Tax58.00
Other loss/ -income5,793.00
Total costs & expenses54,563.00
Income & Taxes
Income / -loss before income taxes6,597.00
Income taxes expenses / -benefit2,364.00
Income after income taxes4,233.00
Income / -loss from continuing operations4,233.00
Non-controlling interests7.00
Net income / -loss4,233.00
Income / -loss to shareholder4,186.00
EBIT9,224.00
EBITD9,986.00
EBITDA17,363.00
Earnings Per Share
Basic EPS (excl. extra items)2.37
Basic Net EPS2.37
Basic shares outstanding (Mill. of Units)1,769.00
Diluted Net EPS2.36
Diluted average shares (Mill. of Units)1,773.00
Dividend per share6.65
4 historic quarters locked

Sign in to unlock the full Abbvie Inc income statement history.

Sign In Create Free Account

About Abbvie Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: February 20, 2026
  • Original filing: abbv-20251231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.